Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-à-gogo K(+) channel.

Author: BaróI, BouyssouT, EscandeD, PotetF

Paper Details 
Original Abstract of the Article :
Agonists of the serotonin 5-hydroxytryptamine 4 (5-HT4) receptor are widely used to activate motility in the gastrointestinal tract. Among these, cisapride was recently withdrawn from the U.S. market because of its proarrhythmic effects. Cisapride is a potent blocker of human ether-à-gogo (HERG) K(+...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/11714889

データ提供:米国国立医学図書館(NLM)

Gastrointestinal Prokinetic Drugs: A Careful Look at Cardiac Effects

Gastrointestinal prokinetic drugs are like skilled guides, helping to navigate the intricate pathways of the digestive system. However, some of these drugs have been known to cause unexpected side effects, particularly affecting the heart. This study investigates the effects of different gastrointestinal prokinetic drugs on the human ether-à-gogo (HERG) K+ channel, a key player in regulating heart rhythm.

Navigating the Desert of Cardiac Safety

The study highlights the importance of considering the potential cardiac effects of gastrointestinal prokinetic drugs. It's like being aware of the presence of hidden quicksand in the desert and taking precautions to avoid it. The researchers found that some prokinetic drugs, like cisapride, can block HERG channels, potentially disrupting heart rhythm. However, they identified other drugs, like mosapride, that did not show this effect, providing a safer alternative.

Ensuring a Safe Journey Through the Digestive System

This study emphasizes the need for careful consideration when prescribing gastrointestinal prokinetic drugs, particularly those that can affect cardiac function. It's like choosing a trusted guide who understands the dangers of the desert and can lead the way safely. By understanding the potential risks and benefits of different drugs, clinicians can select the most appropriate treatment for each patient, ensuring a smooth and safe journey through the digestive system.

Dr.Camel's Conclusion

This study underscores the importance of considering the potential cardiac effects of gastrointestinal prokinetic drugs, emphasizing the need for careful selection and monitoring. Just like a camel guide must be aware of the desert's hidden dangers, clinicians must have a comprehensive understanding of the potential risks and benefits of these medications to ensure the safety and well-being of their patients.
Date :
  1. Date Completed 2001-12-20
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

11714889

DOI: Digital Object Identifier

11714889

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.